Increased risk of esophageal squamous cell carcinoma in patients with gastric atrophy: Independent of the severity of atrophic changes

International Journal of Cancer

Volumn 124, Issue 9, 2009, Pages 2135-2138

  De Vries, Annemarie C ^a   Capelle, Lisette G ^a   Looman, Caspar W N ^a   Van Blankenstein, Mark ^a   Van Grieken, Nicole C T ^b   Casparie, Mariël K ^c   Meijer, Gerrit A ^a   Kuipers, Ernst J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Prismant Health Care and Advise Institute   (Netherlands)

Author keywords

Atrophic gastritis; Dysplasia; Esophageal squamous cell carcinoma; Gastric atrophy; Intestinal metaplasia

Indexed keywords

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPLASIA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; FOLLOW UP; HUMAN; INTESTINE METAPLASIA; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRIORITY JOURNAL; STOMACH ATROPHY; STOMACH DISEASE; COHORT ANALYSIS; ESOPHAGUS TUMOR; INCIDENCE; METABOLISM; METAPLASIA; MIDDLE AGED; PATHOLOGY; PRECANCER; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SQUAMOUS CELL CARCINOMA; STOMACH MUCOSA;

AGED; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; GASTRIC MUCOSA; GASTRITIS, ATROPHIC; HUMANS; INCIDENCE; MALE; METAPLASIA; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 63449140158     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23955     Document Type: Article

References (28)

1. Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006;19:449-490 (Pubitemid 44134306)
2. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-781 (Pubitemid 46854190)
3. Ye W, Held M, Lagergren J, Engstrand L, Blot WJ, McLaughlin JK, Nyren O. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst 2004;96:388-396 (Pubitemid 38351300)
4. Wu AH, Crabtree JE, Bernstein L, Hawtin P, Cockburn M, Tseng CC, Forman D. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer 2003;103:815-821 (Pubitemid 36110240)
5. Chow WH, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, Risch HA, Perez-Perez GI, Schoenberg JB, Stanford JL, Rotterdam H, West AB, Fraumeni JF, Jr. An inverse relation between cagA1 strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998;58:588-590
6. Vicari JJ, Peek RM, Falk GW, Goldblum JR, Easley KA, Schnell J, Perez-Perez GI, Halter SA, Rice TW, Blaser MJ, Richter JE. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998;115:50-57 (Pubitemid 28307287)
7. Bahmanyar S, Zendehdel K, Nyren O, Ye W. Risk of oesophageal cancer by histology among patients hospitalised for gastroduodenal ulcers. Gut 2007;56:464-468 (Pubitemid 46580499)
8. Ye W, Nyren O Risk of cancers of the oesophagus and stomach by histology or subsite in patients hospitalised for pernicious anaemia. Gut 2003;52:938-941 (Pubitemid 36765282)
9. Iijima K, Koike T, Abe Y, Inomata Y, Sekine H, Imatani A, Nakaya N, Ohara S, Shimosegawa T. Extensive gastric atrophy: an increased risk factor for superficial esophageal squamous cell carcinoma in Japan. Am J Gastroenterol 2007;102:1603-1609 (Pubitemid 47206685)
10. Rakic S, Dunjic MS, Pesko P, Milicevic M. Atrophic chronic gastritis in patients with epidermoid carcinoma of the esophagus. J Clin Gastroenterol 1993;17:84. (Pubitemid 23193785)
11. McColl KE. Helicobacter pylori and oesophageal cancer-not always protective. Gut 2007;56:457-459 (Pubitemid 46580495)
12. Kneller RW, You WC, Chang YS, Liu WD, Zhang L, Zhao L, Xu GW, Fraumeni JF, Jr, Blot WJ. Cigarette smoking and other risk factors for progression of precancerous stomach lesions. J Natl Cancer Inst 1992;84:1261-1266
13. Russo A, Maconi G, Spinelli P, Felice GD, Eboli M, Andreola S, Ravagnani F, Settesoldi D, Ferrari D, Lombardo C, Bertario L. Effect of lifestyle, smoking, and diet on development of intestinal metaplasia in H. pylori-positive subjects. Am J Gastroenterol 2001;96:1402-1408 (Pubitemid 32455066)
14. Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Dubrow R, Rotterdam H, West AB, Blaser M, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 2003;95:1404-1413
15. Kuipers EJ, Uyterlinde AM, Pena AS, Roosendaal R, Pals G, Nelis GF, Festen HP, Meuwissen SG. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995;345:1525-1528
16. Guarner J, Herrera-Goepfert R, Mohar A, Sanchez L, Halperin D, Ley C, Parsonnet J. Gastric atrophy and extent of intestinal metaplasia in a cohort of Helicobacter pylori-infected patients. Hum Pathol 2001;32:31-35 (Pubitemid 32150625)
17. Jackman DM, Johnson BE. Small-cell lung cancer. Lancet 2005;366:1385-1396 (Pubitemid 41443406)
18. Casparie M, Tiebosch T, Burger G, Blauwgeers H, van de Pol A, van Krieken J, Meijer G. Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol 2007;29:19-24. (Pubitemid 46535194)
19. Cote RA, Robboy S. Progress in medical information management. Systematized nomenclature of medicine (SNOMED). JAMA 1980;243:756-762
20. Statistics Netherlands. [Internet] 2008. [cited June 2008] Available at: www.cbs.nl. 2007.
21. [Internet] 2008 [cited June 2008]. Available at: www.ikcnet.nl. 2003.
22. de Vries AC, Meijer GA, Looman CW, Casparie MK, Hansen BE, van Grieken NC, Kuipers EJ. Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands. Gut 2007;56:1665-1670 (Pubitemid 350206290)
23. Hold GL, Rabkin CS, Chow WH, Smith MG, Gammon MD, Risch HA, Vaughan TL, McColl KE, Lissowska J, Zatonski W, Schoenberg JB, Blot WJ, et al. A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 2007;132:905-912
24. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
25. Moons LM, Kuipers EJ, Rygiel AM, Groothuismink AZ, Geldof H, Bode WA, Krishnadath KK, Bergman JJ, van Vliet AH, Siersema PD, Kusters JG. COX-2 CA-haplotype is a risk factor for the development of esophageal adenocarcinoma. Am J Gastroenterol 2007;102:2373-2379 (Pubitemid 47631756)
26. Nordenstedt H, Nilsson M, Johansson S, Wallander MA, Johnsen R, Hveem K, Lagergren J. The relation between gastroesophageal reflux and respiratory symptoms in a population-based study: the Nord-Trøndelag health survey. Chest 2006;129:1051-1056
27. Kitamura Y, Umemura T, Kanki K, Ishii Y, Kuroiwa Y, Masegi T, Nishikawa A, Hirose M. Lung as a new target in rats of 2-amino-3-methylimidazo[4,5-f] quinoline carcinogenesis: results of a two-stage model initiated with N-bis(2-hydroxypropyl)nitrosamine. Cancer Sci 2006;97:368-373
28. de Vries AC, van Grieken NC, Looman CW, Casparie MK, de Vries E, Meijer GA, Kuipers EJ. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 2008;134:945-952